Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

5-Star Stocks Poised to Pop: IDEXX Labs

By Brian D. Pacampara, CFA - Nov 1, 2012 at 8:50PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Market-trouncing returns could be written in this 5-Star.

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, veterinary services provider IDEXX Laboratories ( IDXX 3.25% ) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at IDEXX and see what CAPS investors are saying about the stock right now.

IDEXX facts

Headquarters (founded)

Westbrook, Maine (1983)

Market Cap

$5.3 billion

Industry

Healthcare equipment

Trailing-12-Month Revenue

$1.3 billion

Management

Chairman/CEO Jonathan Ayers

CFO Merilee Raines

Return on Equity (average, past 3 years)

27.7%

Cash/Debt

$221.4 million / $234.7 million

Competitors

Abaxis ( ABAX )

Heska ( HSKA 7.60% )

VCA Antech ( WOOF )

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 95% of the 237 members who have rated IDEXX believe the stock will outperform the S&P 500 going forward.

About a month ago, one of those bulls, fellow Fool John Divine (TMFDivine), succinctly summed up the outperform case for our community:

Love how this company offers diagnostic products and veterinarian management systems, and is integrating these into a single service. People love their pets and this company is on top of a very niche area. This stock should continue to outperform over the next few years.

If you want market-topping returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite its five-star rating, IDEXX may not be your top choice.

We've found another growth play we are incredibly excited about -- excited enough to dub it "The Only Stock You Need to Profit from the NEW Technology Revolution." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

IDEXX Laboratories, Inc. Stock Quote
IDEXX Laboratories, Inc.
IDXX
$611.43 (3.25%) $19.22
Abaxis, Inc. Stock Quote
Abaxis, Inc.
ABAX
Heska Corporation Stock Quote
Heska Corporation
HSKA
$175.71 (7.60%) $12.41
VCA Inc. Stock Quote
VCA Inc.
WOOF

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
633%
 
S&P 500 Returns
140%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/08/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.